BM

Biomarin Pharmaceutical IncNASDAQ BMRN Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

13.228

Large

Exchange

XNAS - Nasdaq

View Section: Eyestock Rating

Biomarin Fair Value

BM

The fair market value of BMRN stock is 210.06 USD. Relative to the market price of 66.4758 USD Biomarin is undervalued by 216.4%

Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.

Fair Relative Value

Undervalued 216.4%
210.06 USD
BMRN Fair Value
66.476 USD
Market price of BMRN

Biomarin Valuation

Current BMRN share ticker price is 66.4758 USD.

The fair value level of 210.06 USD can be considered as an effective entry point for long-term investors to start investing in BMRN stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Current price is 216% lower its fair value

Min value

Current price is 53% higher its minimum value

Max value

Current price is 626% lower its maximum value

23.12.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

BMRN stock is undervalued

It means the current price may concern as a Moderate Risk Entry Point

Biomarin Pharmaceutical Inc Stock Valuation Calculator

How do we value a stock?

As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.

1

Maximum P/E over 5 years

284.07

2

Median P/E over 5 years

123.59

3

Minimum P/E over 5 years

18.21

4

Earning per share (last 12 months)

1.7 USD

Maximum value

1

x

4

=

482.84 USD

Fair value

2

x

4

=

210.06 USD

Minimum value

3

x

4

=

30.96 USD

Biomarin Pharmaceutical Inc price metrics

-4.6

Annual return (geometric mean)

39.63

Risk (standard deviation) of returns

β

0.29

Beta (volatility compared to market)

It means that BMRN stock is less volatile than the broader market

Discover Undervalued Companies


View Section: Profitability